Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

This publication has 37 references indexed in Scilit:

• Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock
  Critical Care Medicine, 1996
• Episodic activation off the coagulation system in unstable angina does not elicit an acute phase reaction
  The American Journal of Cardiology, 1996
• Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice
  Immunity, 1995
• Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury
  Critical Care Medicine, 1995
• Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors
  European Journal of Clinical Investigation, 1994
• Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial
  Critical Care Medicine, 1994
• Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells
  Atherosclerosis, 1993
• Production of interleukin-1-receptor antagonist during experimental endotoxaemia
  The Lancet, 1991
• Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
  The Journal of Infectious Diseases, 1990
• Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.
  Journal of Clinical Investigation, 1989